ArticleKidney international reports2026

Rituximab and Cycle-Synchronized Prednisone for Immune Checkpoint Inhibitor Rechallenge in Minimal Change Disease.

Hariharan Seshadri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.